EUVIMEDEUVIMED entdecken
Crossref

Post COVID-19 vaccine (SINOVAC) cerebral venous sinus thrombosis

Soban Khan, Mariam Khalil, Zaid Waqar

Pakistan Journal of Neurological Sciences · 2022

DOI: 10.56310/pjns.v17i02.185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pakistan Journal of Neurological Sciences, 2022. Verfasst von Soban Khan und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sinovac is an inactivated virus COVID 19 vaccine given emergency authorization for COVID 19 Pandemic. Different adverse reactions have been seen in after marketing of COVID 19 vaccines. Here we present a case of patient who developed cerebral venous sinus thrombosis two weeks after the first dose of SINOVAC vaccine.

Zitieren

APA

Khan, S., Khalil, M., & Waqar, Z. (2022). Post COVID-19 vaccine (SINOVAC) cerebral venous sinus thrombosis. Pakistan Journal of Neurological Sciences. https://doi.org/10.56310/pjns.v17i02.185

Vancouver

Khan S, Khalil M, Waqar Z. Post COVID-19 vaccine (SINOVAC) cerebral venous sinus thrombosis. Pakistan Journal of Neurological Sciences. 2022. doi:10.56310/pjns.v17i02.185

BibTeX
@article{Khan2022,
  author = {Khan, Soban and Khalil, Mariam and Waqar, Zaid},
  title = {Post COVID-19 vaccine (SINOVAC) cerebral venous sinus thrombosis},
  journal = {Pakistan Journal of Neurological Sciences},
  year = {2022},
  doi = {10.56310/pjns.v17i02.185}
}
Kostenlos starten →